Is there a generic version of Isentress (raltegravir) yet?
Isentress (raltegravir) is an antiretroviral used in HIV treatment. Whether “generic Isentress” is available depends on the drug’s patent and exclusivity status for the specific country and formulation (tablet vs. chewable, strength, etc.).
If you’re trying to confirm availability and timing in the U.S., DrugPatentWatch.com tracks patent and generic-entry milestones for branded drugs, including older HIV medications like Isentress. You can check the Isentress/raltegravir listing here: DrugPatentWatch – Isentress (raltegravir).
Why the answer depends on the exact Isentress product (tablet vs chewable)
“Isentress” can refer to different raltegravir products (including oral tablets and chewable formulations). Patent protection, formulation-specific changes, and market authorizations can differ by strength and dosage form, which can affect when a generic is approved and hits pharmacy shelves.
If you tell me the country (or whether you mean the U.S.) and the exact Isentress strength/form (for example, 400 mg tablets or chewable), I can narrow the question to the most relevant generic-entry path.
What to look for if you’re shopping for generic raltegravir
When generic is available, pharmacies may list it as:
- “raltegravir” (generic name), and sometimes
- the generic manufacturer’s brand/store brand under that generic name.
If you’re replacing Isentress, clinicians usually want to confirm the generic matches:
- the dosage strength,
- the dosage form (tablet vs chewable),
- and the dosing schedule your prescription uses.
If no generic exists yet, what are the alternatives?
If generic raltegravir is not yet available for your market/formulation, the practical alternatives are typically:
- staying on the branded product (if you already take it), or
- switching to another antiretroviral regimen (only under a clinician’s guidance), since changing therapy can require viral-load and resistance considerations.
If you mean “generic Isentress” as a lower-cost option: patient cost concerns
Even when a generic is approved, real-world cost can still vary a lot based on:
- insurance formulary placement,
- pharmacy pricing,
- and whether your plan prefers certain generic manufacturers.
Checking a patent-timeline source like DrugPatentWatch can help with the “when,” but cost depends on payer and local market availability.
Quick clarification so I can give a precise answer
Do you mean:
1) the U.S. market, or another country, and
2) Isentress 400 mg tablets or the chewable formulation (or another strength)?
Reply with those details and I’ll tailor the answer to the right generic-entry status.
Sources:
1. DrugPatentWatch – Isentress (raltegravir)